Atlas Quant

Cover Block

PUBLIC

Attribute	Value
Company Name	Atlas Quant
Tagline	AI platform for institutional evaluation of trading strategies and track records
Headquarters	London, United Kingdom
Business Model	SaaS
Industry	Fintech
Technology	AI / Machine Learning
Geography	Western Europe
Growth Profile	Venture Scale
Founding Team	Solo Founder

Links

PUBLIC

• Website: https://www.atlasquant.io/
• LinkedIn: https://www.linkedin.com/company/atlas-quant

Executive Summary

PUBLIC

Atlas Quant is an early-stage London fintech building an AI platform to automate the forensic evaluation of trading strategies and track records for institutional allocators, a niche with high potential value if it can overcome the opacity and statistical noise that currently plagues manager selection [Atlas Quant website, November 2025]. The company, founded by solo founder Selim Adyel, launched its flagship Atlas Prime product in November 2025, positioning it to address what it calls a $20 billion-plus global market for institutional due diligence [EINPresswire, November 2025]. The core proposition is a no-code, AI-powered system that promises to quantify the robustness, persistence, and anomaly risk of both quantitative and discretionary strategies across asset classes, aiming to replace labor-intensive, qualitative analyst reviews with a standardized analytical layer.

Founder Selim Adyel brings a relevant quantitative finance pedigree to the venture, with a decade of experience building and managing strategies at firms including Morgan Stanley, UBS, and Caxton Associates, where he supported global macro investments [eFinancialCareers, 2018] [Udemy, 2026]. This background suggests a founder-led insight into the specific pain points the product aims to solve. The business model is SaaS, targeting allocators, though specific pricing and go-to-market details are not yet public.

For investors, the immediate focus is on validation. The company claims its infrastructure is already analyzing over $70 billion in assets under management across "leading global allocators," but no specific client names or revenue figures are disclosed [Atlas Quant website, November 2025]. The next 12 to 18 months will be critical for moving from a founder-driven product launch to demonstrating commercial traction, securing initial institutional customers, and likely raising its first external capital to build out a commercial and product team beyond the founder.

Data Accuracy: YELLOW -- Key claims (market size, AUM, founder background) are sourced from the company's own materials or a single press release; no independent third-party verification of commercial metrics is available.

Taxonomy Snapshot

Axis	Classification
Business Model	SaaS
Industry / Vertical	Fintech
Technology Type	AI / Machine Learning
Geography	Western Europe (London, United Kingdom)
Growth Profile	Venture Scale
Founding Team	Solo Founder

Company Overview

PUBLIC

Atlas Quant is a London-based fintech company registered as ATLAS QUANT LTD (company number 16472260) [Companies House / GOV.UK, 2026]. The company was founded by Selim Adyel, who serves as its CEO [Atlas Quant website, November 2025]. The founding year is not publicly available.

The founder's background is in quantitative finance. Selim Adyel is a graduate of Ecole Centrale Paris [Selim Adyel LinkedIn, 2026] and has held quantitative roles at Morgan Stanley, UBS Investment Bank, and hedge fund Caxton Associates, where he supported global macro investments [eFinancialCareers, 2018]. His public profile describes ten years of experience building and managing quantitative strategies across equities, global macro, and crypto, with capital managed up to $110 million [Udemy profile, 2026]. He is also listed as the founder and principal of Alphubel Ltd, described as a systematic trading expert [Udemy, 2026].

The company's primary public milestone is the November 2025 launch of its flagship product, Atlas Prime, an AI-powered forensic platform for evaluating trading strategies and track records [EINPresswire, November 2025].

Data Accuracy: YELLOW -- Company registration and founder background corroborated by public filings and professional profiles; launch date confirmed by press release. Founding date and early company history are not publicly available.

Product and Technology

MIXED The company's sole public product is Atlas Prime, an AI platform designed to perform forensic analysis on trading strategies and track records. According to the company, the system allows institutional allocators to evaluate the authenticity of performance data and assess the likelihood of future outperformance, addressing what it calls "a multi-billion-dollar problem of misallocated capital each year" [Atlas Quant website, November 2025]. The platform claims to analyze both quantitative and discretionary strategies across digital and traditional assets, quantifying factors like robustness, persistence, and anomaly risk [EINPresswire, November 2025].

Atlas Quant positions the product as "no-code, institutional-grade strategy evaluation" powered by AI and proprietary quantitative intellectual property [Atlas Quant website, November 2025]. A key claim is that the platform is already processing "$70B+ AUM in live production across leading global allocators," though no specific client names are provided to corroborate this scale of deployment [Atlas Quant website, November 2025]. The technology stack is not detailed in public materials; inferences about a machine learning backend are drawn solely from the product's marketed capabilities and the founder's quantitative background.

Data Accuracy: YELLOW -- Product claims are sourced from company website and a single press release; the $70B+ AUM claim and technical implementation details lack independent verification.

Market Research

PUBLIC

The market for institutional due diligence tools is expanding as allocators seek to replace manual, qualitative assessments with data-driven verification, a shift accelerated by high-profile performance failures and the increasing complexity of quantitative strategies.

Atlas Quant's primary market is defined by the company as "institutional due diligence - verifying whether reported trading performance by traders and portfolio managers truly reflects skill or statistical artefact" [EINPresswire, November 2025]. The company cites a total addressable market (TAM) exceeding $20 billion globally for this specific function [EINPresswire, November 2025]. This figure appears to be a company estimate and is not corroborated by a third-party market research report. For context, the broader market for investment management software, which includes portfolio management, risk analytics, and reporting platforms, was valued at $102.5 billion in 2024 and is projected to grow at a compound annual rate of 12.5% through 2030 [Grand View Research, 2024]. The segment for performance and risk analytics within that broader market is a more direct analog.

Demand is driven by several converging factors. The proliferation of quantitative and AI-driven trading strategies has made performance attribution and risk assessment more complex, moving beyond traditional discretionary manager evaluation. Concurrently, allocators face persistent pressure to identify genuine alpha and avoid capital misallocation, a problem the company claims costs the industry "multi-billion-dollars... each year" [Atlas Quant website, November 2025]. This creates a tailwind for forensic platforms that can automate the detection of statistical anomalies, data mining, or survivorship bias in track records.

Key adjacent markets include traditional portfolio management and risk systems (e.g., Bloomberg PORT, MSCI RiskMetrics) and the growing category of alternative data analytics platforms. These are not direct substitutes but represent established budget lines where due diligence tools could integrate or compete for wallet share. Regulatory forces, particularly in Europe under MiFID II and in the US with evolving SEC guidance on investment adviser marketing, are increasing the scrutiny on performance claims, potentially mandating more rigorous, auditable analysis.

Company-cited TAM | 20 | $B
Analogous Market (Investment Mgmt Software, 2024) | 102.5 | $B

The sizing claims illustrate the ambition of the category but rest on a single, unverified source. The more established analogous market for investment software provides a credible ceiling for potential scale, though the specific due diligence niche Atlas Quant targets remains a small, emerging segment within it.

Data Accuracy: ORANGE - Market sizing is based on a single company press release. The analogous market figure is from a third-party report.

Competitive Landscape

MIXED

Atlas Quant enters a market defined by established quantitative research platforms and a growing number of AI-driven analytics tools, but positions itself as a specialist in forensic evaluation for allocators rather than a general-purpose backtesting engine.

The competitive analysis proceeds as prose.

Mapping the competitive environment requires a segment-by-segment view. The primary incumbents are quantitative research and portfolio construction platforms like Bloomberg PORT and FactSet, which offer extensive performance analytics but are not purpose-built for forensic due diligence on external managers. A second segment includes specialized hedge fund analytics and due diligence providers, such as those offered by major consulting firms or niche data vendors, which often rely on manual processes and standardized questionnaires rather than automated, AI-driven analysis of strategy robustness. The most direct adjacent substitutes are the in-house quantitative teams at large allocators (pension funds, endowments, fund of funds) who build proprietary tools for manager evaluation, representing a build-versus-buy decision for Atlas Quant's target customer.

The company's claimed edge today rests on two pillars: proprietary quantitative IP and a focus on the allocator workflow. The founder's background in building and managing strategies at firms like Caxton Associates and Morgan Stanley suggests the platform's analytical frameworks may be informed by institutional-grade, practitioner-developed methodology [Udemy, 2026]. This domain expertise, if effectively productized, could be a durable differentiator against generic analytics platforms built by software engineers. The second edge is positioning, specifically targeting the allocator's need to verify track record authenticity,a stated "multi-billion-dollar problem",rather than offering tools for traders to optimize their own strategies [Atlas Quant, November 2025]. This focus could carve out a defensible niche.

Exposure is significant and multifaceted. The most critical vulnerability is the lack of a confirmed commercial footprint or disclosed customers, which makes it difficult to assess real-world adoption against any incumbent. A named risk is the potential for large incumbents like Bloomberg or MSCI to introduce similar forensic modules into their existing, deeply embedded workflows, leveraging their vast distribution and client trust. Furthermore, the company does not own a proprietary dataset of manager track records; its value hinges on the analysis of data provided by clients or sourced from public filings. This creates a dependency and limits a potential data moat. The solo-founder structure also raises questions about commercial execution and go-to-market capacity against well-resourced teams.

The most plausible 18-month scenario hinges on proof of commercial adoption. The winner in this segment will likely be the first to secure a marquee, publicly referenceable institutional client,a major pension fund or sovereign wealth fund,that validates the platform's utility in a live due diligence process. If Atlas Quant can achieve this, it establishes credibility as a specialist leader. The loser will be any undifferentiated "AI for quant" tool that fails to move beyond backtesting and into the nuanced, compliance-heavy workflow of institutional allocators. Without a clear beachhead customer, the risk is that the company remains an interesting prototype in a market that ultimately gets addressed by extensions from larger, trusted platform vendors.

Data Accuracy: YELLOW -- Competitive mapping is inferred from the company's stated market position and general industry structure, as no specific competitors are named in available sources. Founder's background provides context for claimed differentiation.

Opportunity

PUBLIC Atlas Quant’s opportunity rests on capturing a meaningful share of the $20 billion-plus market for institutional due diligence by automating a process that currently relies on manual, time-consuming analysis [EINPresswire, November 2025].

The headline opportunity is to become the default forensic platform for allocators evaluating trading strategies, a category-defining layer of infrastructure that could standardize due diligence across both digital and traditional assets. The company’s claim to have $70 billion in assets under management (AUM) in live production, while unverified by independent sources, suggests a foundational beachhead with leading global allocators [Atlas Quant website, November 2025]. If that early traction is real, it provides a credible wedge into a market where trust and proven methodology are paramount. The outcome is plausible because the problem is well-defined: institutional capital is misallocated annually due to an inability to reliably distinguish skill from statistical artifact, creating a clear demand for a systematic solution.

Growth could follow several distinct paths, each hinging on a specific catalyst.

Scenario	What happens	Catalyst	Why it's plausible
Platform Standardization	Atlas Prime becomes the mandated due diligence tool for a major pension fund or sovereign wealth fund.	A landmark partnership with a top-tier allocator, publicly endorsing the platform’s methodology.	The founder’s background includes roles at institutions like Caxton Associates, providing domain credibility for high-stakes evaluations [eFinancialCareers, 2018].
Regulatory Adjacency	Financial regulators or audit firms adopt the platform’s forensic analytics as part of compliance and reporting standards.	Inclusion in a regulatory sandbox or a white-label deal with a Big Four accounting firm.	The product’s stated focus on quantifying “robustness, persistence, and anomaly risk” aligns directly with regulatory concerns over performance reporting [EINPresswire, November 2025].

Compounding for Atlas Quant would likely manifest as a data and reputation flywheel. Each new allocator client contributes proprietary strategy data and track records, which in turn improves the platform’s AI models for detecting anomalies and predicting future outperformance. A more accurate model attracts more sophisticated clients, whose data further entrenches the platform’s advantage. The company’s claim of live production AUM is the first, albeit unconfirmed, signal that this flywheel could be in its earliest stages [Atlas Quant website, November 2025]. Over time, this could create a significant data moat, as the platform’s insights become increasingly difficult for new entrants or manual processes to replicate.

The size of the win can be framed by looking at comparable infrastructure providers in adjacent financial data and analytics markets. While no direct public peer exists for forensic strategy evaluation, companies like MSCI (market cap approximately $40 billion) and FactSet (market cap approximately $16 billion) have built substantial valuations by becoming essential data and analytics providers to institutional investors. Capturing even a single-digit percentage of the cited $20 billion-plus market opportunity through a high-margin SaaS model could support a venture-scale outcome [EINPresswire, November 2025]. This is a scenario-based illustration, not a financial forecast.

Data Accuracy: YELLOW -- Market size and product claims are sourced from a single press release and the company website; the founder's background is corroborated by multiple sources.

Sources

PUBLIC

1. [Atlas Quant, November 2025] Atlas Quant™ - The Institutional Layer for Strategy Evaluation | https://www.atlasquant.io/

2. [EINPresswire, November 2025] Atlas Quant launches Atlas Prime - an AI-powered forensic platform | https://www.einpresswire.com/article/863390195/atlas-quant-launches-atlas-prime-an-ai-powered-forensic-platform-restoring-trust-in-global-trading-performance

3. [eFinancialCareers, 2018] Ex-Morgan Stanley algo trader reappears at hedge fund Caxton Associates | https://www.efinancialcareers.com/news/2018/11/selim-adyel-morgan-stanley-caxton

4. [Udemy, 2026] Selim Adyel | Portfolio manager and senior quantitative researcher | https://www.udemy.com/user/selim-adyel/

5. [Selim Adyel LinkedIn, 2026] Selim Adyel - Atlas Quant | https://www.linkedin.com/in/selimadyel/

6. [Companies House / GOV.UK, 2026] ATLAS QUANT LTD overview - Find and update company information - GOV.UK | https://find-and-update.company-information.service.gov.uk/company/16472260

7. [Grand View Research, 2024] Investment Management Software Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/investment-management-software-market-report